 | Up a level |
2020
Puppe, J., Brambillasca, C., Ratz, L., Bartke, L., van de Ven, M., Bouwman, P., van Tellingen, O., Isensee, J., Hucho, T., van Lohuizen, M., Malter, W., Schmutzler, R., Mallmann, P., Jonkers, J. and Reinhardt, C. (2020). Dual inhibition of EZH2 and ATM displays synergistic cytotoxicity in BRCA1-deficient breast. Geburtshilfe Frauenheilkd., 80 (10). S. E104 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
Puppe, J., Liu, X., Ratz, L., Bartke, L., van de Ven, M., Vliet, M. H., Wientjes, E., van der Gulden, H., Zevenhoven, J., Hahnen, E., Malter, W., Wessels, L. F. A., Schmutzler, R., Mallmann, P., Reinhardt, C., Linn, S. and Jonkers, J. (2020). Double BRCA1 and BRCA2 inactivation is epistatic in mammary tumorigenesis and treatment response to PARP-inhibition and platinum drugs. Geburtshilfe Frauenheilkd., 80 (10). S. E104 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8804
2018
Castiglione, R., Alidousty, C., Wagener, S., Holz, B., Kron, A., Wolf, J., Merkelbach-Bruse, S., Reinhardt, C., Buettner, R. and Schultheis, A. M. (2018). Genetic MET alterations in non-small cell lung cancer: biologic differences and analogies. Virchows Arch., 473. S. S17 - 1. NEW YORK: SPRINGER. ISSN 1432-2307
2017
Meder, L., Schuldt, P., Thelen, M., Dietlein, F., von Baildon, Bergwelt M., Reinhardt, C. and Ullrich, R. T. (2017). Dual inhibition of anti-VEGF and anti-PD-L1 displays synergistic treatment effects in a small cell lung carcinoma mouse model. Oncol. Res. Treat., 40. S. 175 - 176. BASEL: KARGER. ISSN 2296-5262
2016
Meder, L., Schuldt, P., Vlasic, I, Volz, C., Golfmann, K., Zaplatina, A., Florin, A., Tharun, L., Buettner, R., Reinhardt, C. and Ullrich, R. (2016). Combining anti-VEGF therapy and immune checkpoint inhibitors improves outcome in small cell lung carcinomas. Oncol. Res. Treat., 39. S. 87 - 88. BASEL: KARGER. ISSN 2296-5262
2014
Thelen, L., Chen, S., Riabinska, A., Daheim, M., Jokic, M., Thomas, R. and Reinhardt, C. (2014). Therapeutic targeting of a robust non-oncogene addiction to PRKDC in DNA repair-defective tumors. Oncol. Res. Treat., 37. S. 97 - 98. BASEL: KARGER. ISSN 2296-5262